Abdominal aortic aneurysm and peripheral disease
Download
1 / 36

Abdominal Aortic Aneurysm and Peripheral Disease - PowerPoint PPT Presentation


  • 185 Views
  • Uploaded on

Abdominal Aortic Aneurysm and Peripheral Disease. 순천향대학교 부천병원 흉부외과학교실 원 용 순. Contents. AAA General consideration Randomized Control Trials Comparing EVAR and Open AAA repair (OAR) Patient selection criteria for EVAR EVAR procedure Complications of EVAR ; endoleak Experience of SCHBC

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Abdominal Aortic Aneurysm and Peripheral Disease' - shanae


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Abdominal aortic aneurysm and peripheral disease

Abdominal Aortic Aneurysm and Peripheral Disease

순천향대학교 부천병원 흉부외과학교실

원 용 순


Contents
Contents

  • AAA

    • General consideration

    • Randomized Control Trials Comparing EVAR and Open AAA repair (OAR)

    • Patient selection criteria for EVAR

    • EVAR procedure

    • Complications of EVAR ; endoleak

    • Experience of SCHBC

  • Peripheral Disease

    • ACA/AHA Practice Guideline

    • Classification of peripheral arterial disease (PAD)

    • Endovascular procedure

    • Experience of SCHBC

  • Conclusions


Endovascular treatment of aaa endovascular aneurymal repair evar
Endovascular Treatment of AAA; EndoVascular Aneurymal Repair : EVAR

  • Parodi JC, Palmaz JC, Barone HD.Transfemoral intraluminal graft implantation for abdominal aortic aneurysms.

Ann Vasc Surg 1991;5:491-499


Modular endovascular bifurcation prosthesis including main bifurcation segment (A), contralateral leg (B), proximal aortic cuff (C), iliac cuff (D), and bifurcated (E) or straight (F) extenders. CTA, computed tomography-angiography; DSA, digital subtraction angiography

•Stent-graft design incorporating both limited and adjustable dimensional variability for maximum versatility. The fixed attachment points on the left have limited linear variability, whereas the adjustable fixation points on the right result in increased adaptability


Dutch randomized endovascular aneurysm management dream trial
Dutch Randomized Endovascular Aneurysm Management (DREAM) trial

  • Between Nov. 2000 and Dec.2003, Netherlands

  • 351 patients ( > 5cm AAA, suitable for both OSR and EVAR )

  • OSR = 174 pts vs. EVAR = 171 pts

  • Primary end point – operative mortality & moderate or severe complications

NEJM 2004;351:1607-1618


DREAM trial trial

NEJM 2004;351:1607-1618


DREAM trial trial

NEJM 2004;351:1607-1618


Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

  • Sept. 1999 ~ Dec. 2003, UK

  • 1082 patients

    • > 60 years, > 5.5cm AAA

    • AAA was regarded as anatomically suitable for EVAR

    • OSR = 539 pts vs. EVAR = 543 pts

  • to assess long term survival, generalisability, graft durability, health-related quality of life (HRQL), and hospital costs associated with both EVAR and OSR

Lancet 2005 ; 365 :2179 - 86


EVAR trial 1 with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

Lancet 2005 ; 365 :2179 - 86


EVAR trial 1 with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

Lancet 2005 ; 365 :2179 - 86


Patient selection criteria for evar
Patient selection criteria for EVAR with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

  • Fusiform AAA ≥ 5 ~ 5.5cm in diameter

  • Saccular AAA

  • Suggested aortic morphology

    • Proximal neck length ≥ 1.5 cm

    • Neck diameter ≤ 2.8 cm

    • Neck angulation ≤ 60 degrees

    • Preservation of critical side branches

    • Iliofemoral arteries of sufficient diameter for sheath access

    • No severe iliac artery or aortic tortuosity

  • No hereditary connective tissue disorder

  • Anesthesia clearance for possible conversion to open repair if necessary


Patient selection criteria for EVAR with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

Preservation of critical side branches

Proximal neck length ≥ 1.5 cm

Neck angulation ≤ 60 degrees

Fusiform AAA ≥ 5 ~ 5.5cm in diameter or Saccular AAA

No severe iliac artery or aortic tortuosity

Iliofemoral arteries of sufficient diameter for sheath access


Evar procedure
EVAR procedure with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

Preop. CT angiography


Evar procedure1
EVAR procedure with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial


Evar procedure2
EVAR procedure with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

Postop. CT angiography


Complications of evar
Complications of EVAR with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

  • Endoleak

    • Type I, II, III, IV, V

  • Migration

  • Kink, Stenosis, and Occlusion

  • Graft infection

  • Rupture


  • Endoleak
    Endoleak with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    • Type I : a leak between the stent-graft and the proximal or distal arterial wall attachment site

    • Type II : back-bleeding into the aneurysm sac from a patent inferior mesenteric (IMA), lumbar, internal iliac, accessory renal or gonadal artery


    Endoleak1
    Endoleak with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    • Type III : between stent-graft components (e.g. the junction between the main body and limb of a device) or through a hole in the fabric of the graft

    • Type IV : excessive graft porosity

    • Type V (endotension) : when the sac increases in size without a detectable endoleak


    Type s of endoleaks
    Type with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trials of Endoleaks

    I

    IV

    III

    II

    I


    Result of endoleak
    Result of Endoleak with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    • Many type II endoleaks undergo resolution by spontaneous thrombosis

    Frank J. Veithet al. J Vasc Surg 2002;35:1029-35

    Nature and significance of endoleaks and endotension: Summary of opinions expressed at an international conference

    Christopher K. Zarinset al. J Vasc Surg 2000;32:90-107 Endoleak as a predictor of outcome after endovascular aneurysm repair: AneuRx multicenter clinical trial


    Result of endoleak1
    Result of Endoleak with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    Timothy Reschet al. J Vasc Surg 1998;28:242-9

    Persistent collateral perfusion ofabdominal aortic aneurysm afterendovascular repair does not lead toprogressive change in aneurysmdiameter


    Experience of schbc evar for aaa
    Experience of SCHBC with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial- EVAR for AAA

    • Feb, 2008 to May, 2009

    • 13 patients (M : F = 11 : 1)

    • Mean age : 70.54 (54 – 82)

    • Aneurysm size : 56.23mm (32-76.3mm)

      • Ruptured : 1

      • Impending rupture : 2

      • unruptured : 10


    EVAR and OR in SCHBC with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    P<0.05

    Mortality : 2/15(13%) in OR

    1/13(8%) in EVAR


    Experience of schbc endoleak
    Experience of SCHBC with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial- Endoleak

    • Endoleak : 6/13 (46%)

      • type I : 2 ( Ia, Ib)

      • type II : 2

      • type III : 2

    • Result of endoleaks

      • type II & type III : improved, 2wks, 3mths

      • Other

        • loss : 1

        • Follow up : 2

    • Mortality : 1 (type Ia endoleak)


    Peripheral arterial disease pad

    Peripheral Arterial Disease(PAD) with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    ACA/AHA Practice Guideline


    Iliac lesion
    Iliac lesion with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    TransAtlantic Inter-Society Consensus (TASC) Working Group


    Femoral popliteal lesion
    Femoral popliteal lesion with abdominal aortic aneurysm (EVAR trial 1) : randomised controlled trial

    TransAtlantic Inter-Society Consensus (TASC) Working Group


    Aca aha practice guideline endovascular treatment for claudication
    ACA/AHA Practice Guideline – Endovascular treatment for Claudication

    • Recommandations

      • Endovascular procedure is the treatment of choicefor type A lesions in iliac or femoral popliteal lesions

      • More evidence is needed to make firm recommendations about the type B and C lesions

      • Primary stent placement is not recommended in the femoral, popliteal or tibial arteries


    Subintimal angioplasty si pta
    Subintimal Angioplasty (SI-PTA) Claudication

    A schematic diagram to show the subintimal recanalization procedure

    (A) The occlusion is approached away from a collateral

    (B) The catheter/guidewire is advanced through the subintimal space, enabling it to take the path of least resistance

    (C) The catheter is retracted back and the guidewire is manipulated into a wide loop

    (D) The loop is advanced forward until it re-enters the true lumen

    Semin Vasc Surg1995;8:253-264




    Experience of schbc
    Experience of SCHBC Claudication

    • July, 2007 to May, 2009

    • 16 patients (M : F = 14 : 2)

    • not suitable for bypass surgery

      • Anesthesia, poor run off or more peripheral lesion

    • Mean age : 65.2 (47 – 77)

    • Lesions

      • Iliac : 6

      • Femoropopliteal : 7

      • Combine : 3

    • Stent insertion : 14


    Experience of schbc1
    Experience of SCHBC Claudication

    • ABI follow up (POD # 7)

      • Pre PTA (mean) : Post PTA = 0.44 : 0.94

    • Post PTA amputation of extremities

      • 2 pts (2nd toe Rt., BK amputation both)

    P =0.009


    Conclusions
    Conclusions Claudication

    • EVAR is a effective and feasible procedure in patients at low surgical risk as well as at high risk

    • In randomized studies, EVAR is superior to the open repair at short-term and midterm results

    • In SCHBC experience, perioperative results in EVAR are more acceptable than them of open repair


    Conclusions1
    Conclusions Claudication

    • Endovascular procedure is an another option in treatment methods of patient with PAD

    • Endovascular procedure, especially, is more effective and feasible in PAD patients with high surgical risk, poor run off and more peripheral lesions

    • More research is needed to make sure of the effects of endovascular procedure for patients with PAD



    ad